- Report
- November 2025
- 160 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- October 2025
- 160 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- September 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Report
- August 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Newsletter
- February 2026
Global
€2621EUR$2,995USD£2,279GBP
- Report
- February 2025
- 246 Pages
United States
From €4200EUR$4,799USD£3,651GBP
- Report
- June 2025
- 95 Pages
Asia Pacific
From €3457EUR$3,950USD£3,005GBP
- Report
- March 2022
- 405 Pages
Global
From €4200EUR$4,799USD£3,651GBP
- Report
- August 2024
- 373 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- April 2023
- 282 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- June 2023
- 100 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- April 2023
- 120 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- February 2024
- 120 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- September 2025
- 150 Pages
Canada
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global

Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments.
The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated.
Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more